The synergistic use of Celigo and CQ1 enhances research efficiency by combining rapid initial screenings with detailed high-resolution imaging. This approach is beneficial for core facilities and ambitious labs aiming to push their research boundaries.

Our latest product has very little to do with cell imaging, but is nevertheless and despite it's tiny size (and price, for that matter) a tool that can very much change the view on a critical parameter in life science and medical treatments …

Product specialist Jonas Schäfer talks about an exciting recent publication by Kovács and colleagues using Cytosurge's FluidFM technology.

Research in the field of the immune system is more in focus because of several reasons. We all still remember the challenging situation during the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where mRNA-based vaccination helped to overcome the vaccination gap (1, 2). And hence proved to be a valuable tool for fighting diseases. This is why there are high hopes to use similar technology to target cancer by means of vaccination and by triggering the immune response.

Read about a new publication about virus-peptide interactions by Feola et al. (eLife, 2022).